BEUDAMED
    12 results · 18ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

    SUMMIT TECH 19/20 GAUGE OPHTHALMIC FIBERENDOSCOPE

    FDA 510(k)
    FDA Class 1 ·Ear, Nose, Throat

    NuVasive

    FDA UDI
    Nuvasive, Inc.·00887517389077·Universal Rasp, Angled

    ORA Implant Abutment 2.0mm Cuff (BD)

    FDA UDI
    STERNGOLD DENTAL LLC·00841549111556·The ORA System is indicated for use with dental...

    Convaid

    FDA UDI
    CONVAID PRODUCTS, INC.·10840117400150·

    SEARS MODEL JCS IN-THE-EAR HEARING INSTRUMENT

    FDA 510(k)
    FDA Class 1 ·Ear, Nose, Throat

    IN-THE NEBULIZER

    FDA 510(k)
    FDA Class 2 ·Anesthesiology

    SOFTCLIX® LANCET DEVICE

    FDA Adverse Event
    Malfunction ·ROCHE DIAGNOSTICS·Product code FMK·November 22, 2010

    OT VERIO PRO PLUS METER

    FDA Adverse Event
    Malfunction ·LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL·Product code NBW·July 1, 2014

    LD304 MATERNITY BED

    FDA Adverse Event
    Malfunction ·STRYKER MEDICAL·Product code HDD·November 30, 2012

    Swift-Lock (TM) Anchor Accessory Kit, Directions For Use Model 1192, ANS, A St. Jude Medical Company. Product is intended to be used as an accessory to the leads component of ANS SCS systems, functioning to secure the lead to the fascia or interspinous/supraspinous ligament.

    FDA Recall
    Terminated ·Advanced Neuromodulation Systems, Inc·Product code GZB·February 22, 2010

    MitraXs" Self Adjusting Atrial Retractor, Sterile EO, Models (REF): A0030/1; A0031/1; A0032/1; A0033/1, Cardio Life Research s.a., Green Hill, Hoge Wei, 16, B-1930 Zaventem, Belgium. Indicted for the retraction of the atrium walls during mitral or tricuspid cardiac surgery.

    FDA Recall
    Terminated ·St. Jude Medical Cardiovascular Division·Product code DWS·January 26, 2011

    Animas(R) 2020 Insulin Infusion Pump Product Usage: This product is indicated for continuous subcutaneous infusion of insulin for the treatment of insulin-requiring diabetes.

    FDA Enforcement
    Class I ·Terminated·Animas Corporation·April 10, 2013